𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expressions of Topoisomerase IIα and BCRP in Metastatic Cells are Associated with Overall Survival in Small Cell Lung Cancer Patients

✍ Scribed by Matija Rijavec; Mira Šilar; Nadja Triller; Izidor Kern; Urška Čegovnik; Mitja Košnik; Peter Korošec

Book ID
107636523
Publisher
Springer Netherlands
Year
2011
Tongue
English
Weight
225 KB
Volume
17
Category
Article
ISSN
1219-4956

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Amplification of the topoisomerase ii α
Amplification of the topoisomerase ii α gene in a non-small cell lung cancer cell line and characterisation of polymorphisms at the human topoisomerase ii α and β loci in normal tissue
✍ W. Nicol Keith; Robert Brown; K. B. Tan 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 738 KB

n sylvan la (K. B.T.) DNA was prepared from normal tissue and I9 lung cancer cell lines. Using probes which detect restriction fragment length polymorphisms at both the topoisomerase II u and p loci, heterozygosity was detected at a frequency of 0. I 7 and 0.37 for the

Expression of syndecan-1 and expression
Expression of syndecan-1 and expression of epidermal growth factor receptor are associated with survival in patients with nonsmall cell lung carcinoma
✍ Lori Shah; Kristin L. Walter; Alain C. Borczuk; Steven M. Kawut; Joshua R. Sonet 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 3 views

## Abstract ## BACKGROUND Recently, the authors identified molecular signatures and pathways associated with nonsmall cell lung carcinoma histology and lung development. They hypothesized that genetic classifiers of histology would provide insight into lung tumorigenesis and would be associated wi

Comparison of DNA topoisomerase IIα expr
Comparison of DNA topoisomerase IIα expression in small cell and nonsmall cell carcinoma of the lung: In search of a mechanism of chemotherapeutic response
✍ Donald G. Guinee Jr.; Joseph A. Holden; John R. Benfield; Madeline L. Woodward; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 803 KB

## BACKGROUND. Small cell carcinoma of the lung (SCLC) is distinguished from nonsmall cell carcinoma (NSCLC) by its exquisite initial sensitivity to chemotherapy. Antineoplastic drugs effective against SCLC include doxorubicin, etoposide, and others. Recently, the molecular target of these drugs h